Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments

Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments

Bibliographic Details
Main Authors:	Alejandro Ramírez-Chacón, Sergi Betriu-Méndez, Ariadna Bartoló-Ibars, Azucena González, Mercè Martí, Manel Juan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Immunology
Subjects:	T cells chimeric antigen receptor (CAR) ligands receptor antigen CAAR
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1078003/full

Similar Items

Ligand-based CAR-T cell: Different strategies to drive T cells in future new treatments
by: Alejandro Ramírez-Chacón, et al.
Published: (2022-09-01)

T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy
by: Elien De Bousser, et al.
Published: (2021-12-01)

CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer
by: Marta Włodarczyk, et al.
Published: (2022-12-01)

Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors
by: Francesco Boccalatte, et al.
Published: (2022-10-01)

CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?
by: Ariadna Bartoló-Ibars, et al.
Published: (2021-09-01)

Engineering switchable and programmable universal CARs for CAR T therapy
by: Delong Liu, et al.
Published: (2019-07-01)

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
by: Zhenguang Wang, et al.
Published: (2018-01-01)

How CAR T Cells Breathe
by: Christopher Forcados, et al.
Published: (2022-04-01)

Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors
by: Qiuqiang Chen, et al.
Published: (2022-12-01)

Tuning the performance of CAR T cell immunotherapies
by: Noah H. Richardson, et al.
Published: (2019-11-01)

Gene Targets of CAR-T Cell Therapy for Glioblastoma
by: Chaoqun Wang, et al.
Published: (2023-04-01)

Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
by: Diana Gumber, et al.
Published: (2022-03-01)

Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation
by: Hejin Jia, et al.
Published: (2019-06-01)

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
by: Piotr Celichowski, et al.
Published: (2023-03-01)

Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
by: Cristina Aparicio, et al.
Published: (2021-10-01)

Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients
by: Cihan Taştan, et al.
Published: (2020-11-01)

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
by: Maria Giraudo, et al.
Published: (2024-03-01)

Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing
by: Gianna M. Branella, et al.
Published: (2021-12-01)

Cytopenia after CAR-T Cell Therapy—A Brief Review of a Complex Problem
by: Naman Sharma, et al.
Published: (2022-03-01)

CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
by: Ler Yie Chan, et al.
Published: (2022-03-01)

Emerging Novel Combined CAR-T Cell Therapies
by: Anh Nguyen, et al.
Published: (2022-03-01)

Specific Activation of T Cells by an ACE2-Based CAR-Like Receptor upon Recognition of SARS-CoV-2 Spike Protein
by: Pablo Gonzalez-Garcia, et al.
Published: (2023-04-01)

Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism
by: Quanjun Yang, et al.
Published: (2022-12-01)

Hurdles to breakthrough in CAR T cell therapy of solid tumors
by: Faroogh Marofi, et al.
Published: (2022-04-01)

Modular Chimeric Antigen Receptor Systems for Universal CAR T Cell Retargeting
by: Ashley R. Sutherland, et al.
Published: (2020-09-01)

CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues
by: Elisabetta Cribioli, et al.
Published: (2022-08-01)

Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors
by: Giuseppe Schepisi, et al.
Published: (2020-09-01)

Geometric parameters that affect the behavior of logic-gated CAR T cells
by: Alexander C. Partin, et al.
Published: (2024-01-01)

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
by: Giuseppe Schepisi, et al.
Published: (2023-03-01)

CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
by: Kaveh Hadiloo, et al.
Published: (2023-05-01)

Adoptive Immunotherapy beyond CAR T-Cells
by: Aleksei Titov, et al.
Published: (2021-02-01)

Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells
by: Lauren C. Fleischer, et al.
Published: (2020-09-01)

Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer
by: Ernesto Lopez, et al.
Published: (2023-12-01)

Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions
by: Norris Lam, et al.
Published: (2023-09-01)

Recent updates on CAR T clinical trials for multiple myeloma
by: Quande Lin, et al.
Published: (2019-11-01)

Optimized NGFR-derived hinges for rapid and efficient enrichment and detection of CAR T cells in vitro and in vivo
by: A. Bister, et al.
Published: (2022-09-01)

T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors
by: Nicholas J. Chandler, et al.
Published: (2020-10-01)

The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies
by: Andriy Zhylko, et al.
Published: (2020-07-01)

Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer
by: Carlos Moreno, et al.
Published: (2022-06-01)

Opportunities for CAR-T Cell Immunotherapy in HIV Cure
by: Gerard Campos-Gonzalez, et al.
Published: (2023-03-01)